ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Expected to Rise, Bank of America Analyst Says
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its target price boosted by Bank of America from $18.00 to $23.00 in a research report issued on Thursday, MarketBeat reports. The brokerage presently has a “hold” rating on the biopharmaceutical company’s stock. Bank of America‘s price target would suggest a potential upside of 4.64% from the […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its target price boosted by Bank of America from $18.00 to $23.00 in a research report issued on Thursday, MarketBeat reports. The brokerage presently has a “hold” rating on the biopharmaceutical company’s stock. Bank of America‘s price target would suggest a potential upside of 4.64% from the […]
